Molecular pharmacology of topiramate: managing seizures and preventing migraine.
about
Alprazolam for essential tremorTopiramate for essential tremorPregabalin for essential tremorModifications of antiepileptic drugs for improved tolerability and efficacyNephrolithiasis in topiramate users.Clinical pharmacology of topiramate in migraine prevention.Familial vulnerability to an unusual cognitive adverse effect of topiramate: Discussion of mechanisms.Topiramate for smoking cessation: a randomized, placebo-controlled pilot study.Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.New drugs for migraineTopiramate for migraine prevention.Topiramate for migraine prophylaxis.Topiramate-induced maculopathy in IgG4-related disease.Topiramate: Safety in migraine patients.Electronegative electroretinogram associated with topiramate toxicity and vitelliform maculopathyNeuropsychiatric adverse effects of centrally acting antiobesity drugs.Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.Topiramate for essential tremor.Topiramate in Migraine Prevention: A 2016 Perspective.Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.Cerebrospinal fluid sodium increases in migraine.Topiramate in combat-related posttraumatic stress disorder.Language disturbances as a side effect of prophylactic treatment of migraine.Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial.A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache.Intractable epistaxis associated with topiramate administration.Paresthesia as a favorable predictor of migraine prophylaxis using topiramate.Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in RatsThe α6 subunit-containing GABA receptor: A novel drug target for inhibition of trigeminal activationHomotaurine, a safe blood-brain barrier permeable GABA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis
P2860
Q24201430-7A5F8489-4936-4AE4-9D59-384C2F2F950BQ24201606-56AAF532-D54F-4F75-A306-A3A9275DD3A4Q24203614-41DEB751-2FE1-479D-B58B-9F8F603B74B7Q24651951-F66682B3-4CBC-4C5B-8475-1C2B46DCFBA9Q33919910-CDC00231-8E29-4E33-9BC3-BA74A3157201Q34200361-F72B5293-BDEF-4408-AA5C-86CFE26B03BCQ34345252-29646466-C2DA-4ECF-9087-FF3DB5AE985CQ34372758-EE33CCCA-2C10-4B0B-A0D7-ADB35745FAA9Q35337675-DB68A022-BBD8-427F-BB76-D6D4D9062856Q36332611-7850472C-FEA7-4975-9E0F-BE7247B5D713Q36407219-99F2526D-D106-4F8D-804B-2788028628DEQ36979333-116143EB-E7C4-4F4B-B183-05EBF6EE4EE9Q37007272-B18FD4CC-C94A-4D23-8387-DAFBC7DE7D9EQ37134423-471CE05E-E1DE-47B7-B768-8F2C4D269374Q37360007-7C989C41-346F-4B2C-816A-D9E0F4FD9A72Q37939362-663FEF82-259F-4EA1-8DD7-5A98E2A67C98Q38098898-B09F234E-6C17-444C-91A6-BF498C080D50Q38836991-7A453629-F55F-4624-8FC5-7F080F56C411Q39024628-32B15A98-EE5F-41C4-A8E5-3FE19977EA15Q39256375-F3B474A9-96A7-4DA9-ACAC-1933771A7FE6Q45301942-2D376DAC-A78E-45E0-A23E-DB999A709D3CQ46066627-25B714C7-A1A1-4742-834F-EA7188C2D137Q46816148-B535EEEF-13BC-4DAC-A450-D9BF6C13E359Q48052079-880C163E-8CBE-40B7-BFBA-627D2A547EB9Q48490823-EA74DB5A-023A-4A9D-AAF2-9892146E7F4CQ50729515-A53A544D-2334-4A3F-BABB-E2A172FE07ECQ51974834-1CAB07CD-918C-45AB-B899-340E32E57575Q57492131-6021AB34-067D-496E-9B8C-FC7E81C7572AQ57997641-AE7256B7-642B-4B25-9291-E8C79685DB06Q58589818-65C1CFC4-8927-4C3C-BBA6-ABFCA7980D82
P2860
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@ast
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@en
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@nl
type
label
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@ast
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@en
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@nl
prefLabel
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@ast
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@en
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@nl
P2860
P1433
P1476
Molecular pharmacology of topiramate: managing seizures and preventing migraine.
@en
P2093
H Steve White
P2860
P304
P356
10.1111/J.1526-4610.2005.4501006.X
P478
45 Suppl 1
P577
2005-04-01T00:00:00Z